Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers.

Por Christoph Burdelski, Erzen Bujupi, Maria Christina Tsourlakis, Claudia Hube-Magg, Martina Kluth, Nathaniel Melling, Patrick Lebok, Sarah Minner, Christina Koop, Markus Graefen, Hans Heinzer, Corinna Wittmer, Guido Sauter, Waldemar Wilczak, Ronald Simon, Thorsten Schlomm, Stefan Steurer, Till Krech
Publicado em 2015-01-01

Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder

Por Tim Mandelkow, Niclas C. Blessin, Eva Lueerss, Laura Pott, Ronald Simon, Wenchao Li, Björn Wellge, Nicolaus F. Debatin, Doris Höflmayer, Jakob R. Izbicki, Franziska Büscheck, Andreas M. Luebke, Corinna Wittmer, Frank Jacobsen, Florian Lutz, Eike Burandt, Stefan Steurer, Guido Sauter, Maria Christina Tsourlakis, Waldemar Wilczak, Andrea Hinsch, Sarah Minner
Publicado em 2019-01-01

Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion

Por Christoph Fraune, Luisa Harms, Franziska Büscheck, Doris Höflmayer, Maria Christina Tsourlakis, Till S. Clauditz, Ronald Simon, Katharina Möller, Andreas M. Luebke, Christina Möller-Koop, Stefan Steurer, Claudia Hube-Magg, Guido Sauter, Sören Weidemann, Patrick Lebok, David Dum, Simon Kind, Sarah Minner, Jakob R. Izbicki, Thorsten Schlomm, Hartwig Huland, Hans Heinzer, Eike Burandt, Alexander Haese, Markus Graefen, Cornelia Schroeder
Publicado em 2020-03-01